Standout Papers

Therapeutics targeting the IL-23 and IL-17 pathway in psoriasis 2021 2026 2022 2024361
  1. Therapeutics targeting the IL-23 and IL-17 pathway in psoriasis (2021)
    Kamran Ghoreschi, Anna Balato et al. The Lancet

Immediate Impact

3 by Nobel laureates 22 from Science/Nature 64 standout
Sub-graph 1 of 21

Citing Papers

Structure of the NLRP3 decamer bound to the cytokine release inhibitor CRID3
2022 StandoutNature
NLRP3 inflammasome in cancer and metabolic diseases
2021 Standout
1 intermediate paper

Works of Charlotta Enerbäck being referenced

Inflammasome polymorphisms confer susceptibility to sporadic malignant melanoma
2012
Genetic support for the role of the NLRP3 inflammasome in psoriasis susceptibility
2012

Author Peers

Author Last Decade Papers Cites
Charlotta Enerbäck 1491 1001 429 589 59 2.4k
Cheryl Nickerson‐Nutter 1741 758 564 444 44 3.2k
Xianying Xing 1835 782 425 1067 53 3.0k
Erle Dang 1186 785 303 758 104 2.4k
Pankaj Gupta 978 604 446 470 69 2.5k
Giancarlo Marone 1425 609 663 240 59 3.1k
R. Christopher Benyon 1257 1062 511 174 49 5.0k
Min Hee Oh 1666 1139 657 673 43 3.6k
Rotraut Mößner 1108 575 235 820 90 2.3k
Metin Artuc 1133 701 167 537 55 2.5k
Xuesong Wu 763 893 537 331 88 2.1k

All Works

Loading papers...

Rankless by CCL
2026